Circulating smooth muscle progenitor cells: Novel players in plaque stability

Cardiovascular Research

Volumn 77, Issue 3, 2008, Pages 445-447

  Satoh, Kimio ^a   Berk, Bradford C ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; COLLAGEN;

ACUTE CORONARY SYNDROME; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROTIC PLAQUE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; EDITORIAL; ENDOTHELIUM CELL; EXPERIMENTAL MOUSE; HUMAN; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; STEM CELL; STEM CELL TRANSPLANTATION;

ANIMALS; ATHEROSCLEROSIS; BONE MARROW CELLS; CELL COUNT; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR;

EID: 38849088003     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvm088     Document Type: Editorial

References (21)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
2. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-409.
3. Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 2002;106:1199-1204.
4. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004;113:243-252.
5. Hur J, Yang HM, Yoon CH, Lee CS, Park KW, Kim JH et al. Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies. Circulation 2007;116:1671-1682.
6. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460.
7. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438.
8. Walter DH, Rochwalsky U, Reinhold J, Seeger F, Aicher A, Urbich C et al. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler Thromb Vasc Biol 2007;27:275-282.
9. Satoh K, Kagaya Y, Nakano M, Ito Y, Ohta J, Tada H et al. Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice. Circulation 2006;113:1442-1450.
10. Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Ishii N et al. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 2007;100:662-669.
11. Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 2007;77:471-480.
12. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 2003;100:4754-4759.
13. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007;194:46-54.
14. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M et al. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 2002;106:1834-1839.
15. Bentzon JF, Sondergaard CS, Kassem M, Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 2007;116:2053-2061.
16. O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005;97:1027-1035.
17. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91.
18. Garin G, Mathews M, Berk BC. Tissue-resident bone marrow-derived progenitor cells: key players in hypoxia-induced angiogenesis. Circ Res 2005;97:955-957.
19. Yamada T, Kondo T, Numaguchi Y, Tsuzuki M, Matsubara T, Manabe I et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol 2007;27:2363-2369.
20. Hayashida K, Fujita J, Miyake Y, Kawada H, Ando K, Ogawa S et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest 2005;127:1793-1798.
21. Nagaya N, Kangawa K, Kanda M, Uematsu M, Horio T, Fukuyama N et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation 2003;108:889-895.